In vivo antimalarial efficacy of Artemisia afra powder suspensions
Phytomedicine · 2024
DOI: 10.1016/j.phymed.2024.155644 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2024. Verfasst von Annabelle Walz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Parasite Chemotherapy Unit, Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4123 Allschwil, Swi…. Hauptthemen laut MEDLINE: Antimalarials, Artemisia, Malaria, Plasmodium berghei. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: A global death toll of 608,000 in 2022 and emerging parasite resistance to artemisinin, the mainstay of antimalarial chemotherapy derived from the Chinese herb Artemisia annua, urge the development of novel antimalarials. A clinical trial has found high antimalarial potency for aqueous extracts of A. annua as well as its African counterpart Artemisia afra, which contains only trace amounts of artemisinin. The artemisinin-independent antimalarial activity of A. afra points to the existence of other antimalarials present in the plant. However, the publication was retracted due to ethical and methodological concerns in the trial, so the only evidence for antimalarial activity of A. afra is built on in vitro studies reporting efficacy only in the microgram per milliliter range. HYPOTHESIS: Our study aims to shed more light on the controversy around the antimalarial activity of A. afra by assessing its efficacy in mice. In particular, we are testing the hypothesis that A. afra contains a pro-drug that is inactive in vitro but active in vivo after metabolization by the mammalian host. METHODS: Plasmodium berghei-infected mice were treated once or thrice (on three consecutive days) with various doses of A. afra, A. annua, or pure artemisinin. RESULTS: Aqueous powder suspensions of A. annua but not A. afra showed antimalarial activity in mice. CONCLUSION: Our experiments conducted in mice do not support the pro-drug hypothesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Parasite Chemotherapy Unit, Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland; University of Basel, 4001 Basel, Switzerland.
- Parasite Chemotherapy Unit, Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland; Division of Clinical Pharmacology and Toxicology, Department…
- Parasite Chemotherapy Unit, Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland; University of Basel, 4001 Basel, Switzerland. Electronic add…
Zitieren
APA
Walz, A., Lehmann, U., Duthaler, U., Mäser, P., & Wittlin, S. (2024). In vivo antimalarial efficacy of Artemisia afra powder suspensions. Phytomedicine. https://doi.org/10.1016/j.phymed.2024.155644
Vancouver
Walz A, Lehmann U, Duthaler U, Mäser P, Wittlin S. In vivo antimalarial efficacy of Artemisia afra powder suspensions. Phytomedicine. 2024. doi:10.1016/j.phymed.2024.155644
BibTeX
@article{Walz2024,
author = {Walz, Annabelle and Lehmann, Ursula and Duthaler, Urs and Mäser, Pascal and Wittlin, Sergio},
title = {In vivo antimalarial efficacy of Artemisia afra powder suspensions},
journal = {Phytomedicine},
year = {2024},
doi = {10.1016/j.phymed.2024.155644}
}
EUVIMED